Polaryx Therapeutics is a biopharmaceutical company that provides molecule therapeutics development and clinical trial services.
Polaryx Therapeutics has raised $10.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2026.
Polaryx Therapeutics is headquartered in Paramus, United States.
Polaryx Therapeutics is a biopharmaceutical company that provides molecule therapeutics development and clinical trial services.
Polaryx Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Polaryx Therapeutics — Funding & Investors." VCBacked, May 28, 2026, https://www.vcbacked.co/company/polaryx-therapeutics. Accessed August 18, 2026.
VCBacked. (2026). Polaryx Therapeutics — Funding & Investors. Retrieved August 18, 2026, from https://www.vcbacked.co/company/polaryx-therapeutics
{{cite web |title=Polaryx Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/polaryx-therapeutics |website=VCBacked |access-date=August 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated